Concepedia

Publication | Closed Access

Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers

37

Citations

19

References

2017

Year

References

YearCitations

Page 1